DMK PHARMACEUTICALS CORPORATION Revenue
DMK PHARMACEUTICALS CORPORATION reported Revenue of $9.06 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2023-11-14
- DMK PHARMACEUTICALS CORPORATION revenues for the quarter ending 2023-09-30 was $9.06K, a 99.40% decline year-over-year.
- DMK PHARMACEUTICALS CORPORATION revenues for the quarter ending 2023-06-30 was $6.95K, a 82.57% decline year-over-year.
- DMK PHARMACEUTICALS CORPORATION revenues for the quarter ending 2023-03-31 was $1.45M, a 25.85% increase year-over-year.
- DMK PHARMACEUTICALS CORPORATION revenues for the quarter ending 2022-12-31 was $2.15M.
- DMK PHARMACEUTICALS CORPORATION revenues for fiscal 2022 was $4.76M, a 115.34% increase from fiscal 2021.
- DMK PHARMACEUTICALS CORPORATION revenues for fiscal 2021 was $2.21M, a 20.45% decline from fiscal 2020.
- DMK PHARMACEUTICALS CORPORATION revenues for fiscal 2020 was $2.78M, a 87.44% decline from fiscal 2019.
- DMK PHARMACEUTICALS CORPORATION revenues for fiscal 2019 was $22.11M, a 46.58% increase from fiscal 2018.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 6 month as first filed | Revenues 9 month | Revenues 9 month as first filed | Revenues 12 month | Revenues 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-09-30 | $9.06K 10-Q · filed 2023-11-14 | $16.01K derived: sum of 2 quarters · filed 2023-11-14 | $1.47M 10-Q · filed 2023-11-14 | $3.62M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2023-06-30 | $6.95K 10-Q · filed 2023-08-21 | $1.46M 10-Q · filed 2023-08-21 | $3.61M derived: sum of 3 quarters · filed 2023-08-21 | $5.12M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2023-03-31 | $1.45M 10-Q · filed 2023-05-15 | $3.60M derived: sum of 2 quarters · filed 2023-05-15 | $5.11M derived: sum of 3 quarters · filed 2023-11-14 | $5.15M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-12-31 | $2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $3.66M derived: sum of 2 quarters · filed 2023-11-14 | $3.70M derived: sum of 3 quarters · filed 2023-11-14 | $4.76M 10-K · filed 2023-03-16 | ||||
| 2022-09-30 | $1.51M 10-Q · filed 2023-11-14 | $1.55M derived: sum of 2 quarters · filed 2023-11-14 | $2.61M 10-Q · filed 2023-11-14 | $1.54M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $39.85K 10-Q · filed 2023-08-21 | $1.19M 10-Q · filed 2023-08-21 | $34.93K derived: sum of 3 quarters · filed 2023-08-21 | $794.89K derived: sum of 4 quarters · filed 2023-08-21 | ||||
| 2022-03-31 | $1.15M 10-Q · filed 2023-05-15 | -$4.92K derived: sum of 2 quarters · filed 2023-05-15 | $755.04K derived: sum of 3 quarters · filed 2023-05-15 | $2.03M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | -$1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$399.47K derived: sum of 2 quarters · filed 2023-03-16 | $876.00K derived: sum of 3 quarters · filed 2023-03-16 | $2.21M 10-K · filed 2023-03-16 | ||||
| 2021-09-30 | $759.96K 10-Q · filed 2022-11-14 | $2.04M derived: sum of 2 quarters · filed 2022-11-14 | $3.37M 10-Q · filed 2022-11-14 | $4.11M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $1.28M 10-Q · filed 2022-08-10 | $4.01M 10-Q · filed 2021-11-22 | $2.61M 10-Q · filed 2022-08-10 | $8.12M 10-Q · filed 2021-11-22 | $3.35M derived: sum of 3 quarters · filed 2022-08-10 | $4.22M derived: sum of 4 quarters · filed 2022-08-10 | ||
| 2021-03-31 | $1.39M 10-Q · filed 2022-05-16 | $4.11M 10-Q · filed 2021-11-22 | $2.07M derived: sum of 2 quarters · filed 2022-05-16 | $2.94M derived: sum of 3 quarters · filed 2022-05-16 | $6.87M derived: sum of 4 quarters · filed 2022-05-16 | |||
| 2020-12-31 | $679.79K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $1.55M derived: sum of 2 quarters · filed 2022-03-31 | $5.47M derived: sum of 3 quarters · filed 2022-03-31 | $2.78M 10-K · filed 2022-03-31 | $16.53M 10-K · filed 2021-04-15 | |||
| 2020-09-30 | $868.08K 10-Q · filed 2021-11-22 | $4.30M 10-Q · filed 2020-11-09 | $4.79M derived: sum of 2 quarters · filed 2021-11-22 | $2.10M 10-Q · filed 2021-11-22 | $12.89M 10-Q · filed 2020-11-09 | $15.00M derived: sum of 4 quarters · filed 2021-11-22 | ||
| 2020-06-30 | $3.93M 10-Q · filed 2021-11-22 | $8.59M 10-Q · filed 2021-11-22 | $14.13M derived: sum of 3 quarters · filed 2021-11-22 | $20.03M derived: sum of 4 quarters · filed 2021-11-22 | ||||
| 2020-03-31 | $4.66M 10-Q · filed 2021-11-22 | $10.20M derived: sum of 2 quarters · filed 2021-11-22 | $16.11M derived: sum of 3 quarters · filed 2021-11-22 | $21.87M derived: sum of 4 quarters · filed 2021-11-22 | ||||
| 2019-12-31 | $5.54M derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-15 | $11.44M derived: sum of 2 quarters · filed 2021-04-15 | $17.21M derived: sum of 3 quarters · filed 2021-04-15 | $22.11M 10-K · filed 2021-04-15 | ||||
| 2019-09-30 | $5.90M 10-Q · filed 2020-11-09 | $11.67M derived: sum of 2 quarters · filed 2020-11-09 | $16.57M 10-Q · filed 2020-11-09 | $20.73M derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | $5.76M 10-Q · filed 2020-08-17 | $10.67M 10-Q · filed 2020-08-17 | $14.82M derived: sum of 3 quarters · filed 2020-08-17 | $18.66M derived: sum of 4 quarters · filed 2020-08-17 | ||||
| 2019-03-31 | $4.91M 10-Q · filed 2020-05-18 | $9.06M derived: sum of 2 quarters · filed 2020-05-18 | $12.89M derived: sum of 3 quarters · filed 2020-05-18 | $16.81M derived: sum of 4 quarters · filed 2020-05-18 | ||||
| 2018-12-31 | $4.15M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $7.99M derived: sum of 2 quarters · filed 2020-03-30 | $11.91M derived: sum of 3 quarters · filed 2020-03-30 | $15.09M 10-K · filed 2020-03-30 | ||||
| 2018-09-30 | $3.83M 10-Q · filed 2019-11-12 | $7.75M derived: sum of 2 quarters · filed 2019-11-12 | $10.93M 10-Q · filed 2019-11-12 | |||||
| 2018-06-30 | $3.92M 10-Q · filed 2019-08-08 | $7.10M 10-Q · filed 2019-08-08 | ||||||
| 2018-03-31 | $3.18M 10-Q · filed 2019-05-09 | |||||||
| 2017-12-31 | $13.07M 10-K · filed 2019-03-15 |